Basic Searches
Searches without any special characters (listed below) will return items that contain the exact value(s) entered in the search field. This means that searching for "ASPIRIN CALCIUM" won't return any items that have "ASPIRIN GLYCINE CALCIUM" because the search term doesn't match exactly.
Boolean Operators
OR - searches with terms separated by " OR " will return items that contain any of the terms in the search.
Example: "ASPIRIN" OR "CALCIUM" will return items that have strings like "ASPIRIN GLYCINE" and "GLYCINE CALCIUM" because they contain at least one of the terms in the search.

AND - searches with terms separated by " AND " will return items that contain all the terms in the search.
Example: "ASPIRIN" AND "CALCIUM" won't return items that have strings "ASPIRIN GLYCINE" and "GLYCINE CALCIUM" because neither contain both terms, but it will return "ASPIRIN GLYCINE CALCIUM" because it contains both search terms.
version 2.7.1
Substance Class Chemical
Record UNII
1WS297W6MV
Record Status Validated
Record Version
Show Definitional References Hide Definitional References
Download

Details

Stereochemistry ABSOLUTE
Molecular Formula C9H13NO2
Molecular Weight 167.205
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0
Created by admin on Wed Aug 04 01:47:32 EDT 2021
Edited by admin on Wed Aug 04 01:47:32 EDT 2021
Structure of PHENYLEPHRINE

Systematic Names:

  • None recorded

SMILES

CNC[C@H](O)C1=CC(O)=CC=C1

InChI

SONNWYBIRXJNDC-VIFPVBQESA-N
InChI=1S/C9H13NO2/c1-10-6-9(12)7-3-2-4-8(11)5-7/h2-5,9-12H,6H2,1H3/t9-/m0/s1
Name Type Language Details Access References
PHENYLEPHRINE
Domain Jurisdiction Naming Organization
drug  
INN  
EP   HSDB   INN   MART.   MI   VANDF   WHO-DD  
Official Name
English  
R(-)-MEZATON
Common Name
English  
PHENYLEPHRINE, (R)-
Common Name
English  
PHENYLEPHRINE [WHO-DD]
Common Name
English  
PHENYLEPHRINE [VANDF]
Common Name
English  
PHENYLEPHRINE [MI]
Common Name
English  
PHENYLEPHRINE [MART.]
Common Name
English  
PHENYLEPHRINE [INN]
Common Name
English  
PHENYLEPHRINE [HSDB]
Common Name
English  
PHENYLEPHRINE [EP]
Common Name
English  
PHENYLEPHRINE [EP MONOGRAPH]
Common Name
English  
PHENYLEPHRINE MINIMS
Brand Name
English  
METASYNEPHRINE
Common Name
English  
META-SYNEPHRINE
Common Name
English  
M-SYNEPHRINE
Common Name
English  
M-SYMPATOL
Common Name
English  
M-SYMPATHOL
Common Name
English  
M-OXEDRINE
Common Name
English  
J8.601K
Code
English  
AB-101 (PHENYLEPHRINE)
Code
English  
(R)-PHENYLEPHRINE
Common Name
English  
(-)-PHENYLEPHRINE
Common Name
English  
(-)-3 HYDROXY-.ALPHA.-((METHYLAMINO)METHYL)BENZENEMETHANOL
Systematic Name
English  
(-)-1-(3-HYDROXYPHENYL)-2-METHYLAMINOETHANOL
Systematic Name
English  
Classification Tree Code System Code Access References
WHO-ATC R01BA03
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
WHO-ATC R01AB01
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
WHO-ATC R01BA53
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
WHO-ATC C01CA06
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
WHO-ATC S01BB01
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
WHO-ATC S01FB51
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
WHO-ATC S01FB01
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
WHO-ATC S01GA55
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
WHO-ATC R01AA04
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
WHO-ATC S01GA05
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
FDA ORPHAN DRUG 147201
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
FDA ORPHAN DRUG 359011
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
LIVERTOX 773
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
NCI_THESAURUS C29709
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
NDF-RT N0000186105
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
WHO-VATC QC01CA06
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
WHO-VATC QR01AA04
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
WHO-VATC QR01AB01
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
WHO-VATC QR01BA03
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
WHO-VATC QR01BA53
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
WHO-VATC QS01FB01
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
WHO-VATC QS01GA05
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
WHO-VATC QS01GA55
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
Code System Code Type Description Access References
CAS
59-42-7
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
PRIMARY
EVMPD
SUB09788MIG
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
PRIMARY
ChEMBL
CHEMBL1215
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
PRIMARY
DRUG BANK
DB00388
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
PRIMARY
DRUG CENTRAL
2146
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
PRIMARY
ECHA (EC/EINECS)
200-424-8
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
PRIMARY
EPA CompTox
59-42-7
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
PRIMARY
FDA UNII
1WS297W6MV
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
PRIMARY
HSDB
3383
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
PRIMARY
INN
4174
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
PRIMARY
IUPHAR
485
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
PRIMARY
LACTMED
Phenylephrine
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
PRIMARY
MERCK INDEX
M8668
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
PRIMARY Merck Index
MESH
D010656
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
PRIMARY
NCI_THESAURUS
C62067
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
PRIMARY
NDF-RT
N0000009917
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
PRIMARY Adrenergic alpha1-Agonists [MoA]
PUBCHEM
6041
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
PRIMARY
RXCUI
325517
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
ALTERNATIVE
RXCUI
8163
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
PRIMARY
WIKIPEDIA
PHENYLEPHRINE
Created by admin on Wed Aug 04 01:47:32 EDT 2021 , Edited by admin on Wed Aug 04 01:47:32 EDT 2021
PRIMARY
Related Record Type Details Access References
SALT/SOLVATE -> PARENT
none
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 01:47:33 EDT 2021 , Edited by admin on Wed Aug 04 01:47:33 EDT 2021
SALT/SOLVATE -> PARENT
none
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 01:47:33 EDT 2021 , Edited by admin on Wed Aug 04 01:47:33 EDT 2021
BINDER->LIGAND
Mediator Substance Details
none
BINDING
Created by admin on Wed Aug 04 01:47:33 EDT 2021 , Edited by admin on Wed Aug 04 01:47:33 EDT 2021
SALT/SOLVATE -> PARENT
none
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 01:47:33 EDT 2021 , Edited by admin on Wed Aug 04 01:47:33 EDT 2021
TARGET -> AGONIST
none
Mediator Substance Details
none
Created by admin on Thu Aug 05 04:09:26 EDT 2021 , Edited by admin on Thu Aug 05 04:09:26 EDT 2021
BASIS OF STRENGTH->SUBSTANCE
Mediator Substance Details
none
ASSAY (TITRATION)
EP
Created by admin on Wed Aug 04 01:47:33 EDT 2021 , Edited by admin on Wed Aug 04 01:47:33 EDT 2021
RACEMATE -> ENANTIOMER
none
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 01:47:33 EDT 2021 , Edited by admin on Wed Aug 04 01:47:33 EDT 2021
SALT/SOLVATE -> PARENT
none
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 01:47:33 EDT 2021 , Edited by admin on Wed Aug 04 01:47:33 EDT 2021
SALT/SOLVATE -> PARENT
none
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 01:47:33 EDT 2021 , Edited by admin on Wed Aug 04 01:47:33 EDT 2021
SALT/SOLVATE -> PARENT
none
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 01:47:33 EDT 2021 , Edited by admin on Wed Aug 04 01:47:33 EDT 2021
Related Record Type Details Access References
IMPURITY -> PARENT
Mediator Substance Details
none
CHROMATOGRAPHIC PURITY (HPLC/UV)
For the calculation of contents, multiply the peak areas by 0.5
EP
Created by admin on Wed Aug 04 01:47:33 EDT 2021 , Edited by admin on Wed Aug 04 01:47:33 EDT 2021
IMPURITY -> PARENT
Mediator Substance Details
none
CHROMATOGRAPHIC PURITY (HPLC/UV)
For the calculation of contents, multiply the peak areas by 0.5
EP
Created by admin on Wed Aug 04 01:47:33 EDT 2021 , Edited by admin on Wed Aug 04 01:47:33 EDT 2021
IMPURITY -> PARENT
Mediator Substance Details
none
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Created by admin on Wed Aug 04 01:47:33 EDT 2021 , Edited by admin on Wed Aug 04 01:47:33 EDT 2021
IMPURITY -> PARENT
Mediator Substance Details
none
UNSPECIFIED
EP
Created by admin on Wed Aug 04 01:47:33 EDT 2021 , Edited by admin on Wed Aug 04 01:47:33 EDT 2021
Related Record Type Details Access References
ACTIVE MOIETY
none
none
Mediator Substance Details
none
Created by admin on Wed Aug 04 01:47:33 EDT 2021 , Edited by admin on Wed Aug 04 01:47:33 EDT 2021
Name Property Type Amount Referenced Substance Defining Parameters Access References
Volume of Distribution PHARMACOKINETIC
Vdss PHARMACOKINETIC
Biological Half-life PHARMACOKINETIC
Created Wed Aug 04 01:47:32 EDT 2021
Created By admin
Last Edited Wed Aug 04 01:47:32 EDT 2021
Last Edited By admin
Index Source Text / Citation Source Type Tags Date Accessed File Access
1 USP Dictionary 2010 SRS NOMEN
2 https://www.clinicalkey.com/pharmacology/monograph/482?sec=monphar CLINICAL PHARMACOLOGY
3 INN Proposed List 1 INN_LIST PUBLIC_DOMAIN_RELEASE
4 MARTINDALE 2011 SRS NOMEN
5 EP 7.2 SRS NOMEN
6 KEGG 2011 SRS NOMEN
7 PHENYLEPHRINE [WHO-DD] SRS_LOCATOR
8 PHENYLEPHRINE [INN] SRS_LOCATOR
9 USP DICTIONARY 2014 SRS NOMEN PUBLIC_DOMAIN_RELEASE AUTO_SELECTED
10 PHENYLEPHRINE [EP] SRS_LOCATOR
11 Generated from relationship on:'ALPHA-1A ADRENERGIC RECEPTOR' SYSTEM
12 WHO-DD SRS NOMEN
13 STN STN (SCIFINDER) PUBLIC_DOMAIN_RELEASE
14 SRS CODE IMPORT SRS NOMEN Fri Apr 28 14:27:59 EDT 2017
15 MERCK INDEX SRS NOMEN
16 http://nikkajiweb.jst.go.jp/nikkaji_web/pages/top_e.jsp?CONTENT=syosai&SN=J8.601K SRS NOMEN
17 EP 10.5 EP
18 FDA_SRS SRS NOMEN
19 WEBSITE WEBSITE NOMEN PUBLIC_DOMAIN_RELEASE
20 SYSTEM
21 USP Dictionary SRS NOMEN
22 HSDB SRS NOMEN
23 PHENYLEPHRINE [HSDB] SRS_LOCATOR
24 dump-public-2021-07-22_UPDATED.gsrs BATCH_IMPORT Wed Aug 04 01:47:32 EDT 2021
25 NCT03592121 CLINICAL_TRIALS.GOV NOMEN CLIN
26 WEBSITE WEBSITE NOMEN PUBLIC_DOMAIN_RELEASE
27 WEBSITE WEBSITE NOMEN PUBLIC_DOMAIN_RELEASE
28 http://www.fda.gov/ohrms/dockets/ac/07/briefing/2007-4335b1-01-Schering-Plough.pdf WEBSITE NOMEN
29 NDF-RT SRS NOMEN
30 EP 10.5 EP NOMEN PUBLIC_DOMAIN_RELEASE
31 Drug Information Handbook, 2016-2017 - 25th edition; Lexicomp Drug Reference Handbook; ISBN13: 9781591953531 BOOK PUBLIC_DOMAIN_RELEASE
32 D08365 KEGG NOMEN
33 PHENYLEPHRINE [MI] SRS_LOCATOR
34 PHENYLEPHRINE [VANDF] SRS_LOCATOR
35 EP 7.8 PHENYLEPHRINE MONOGRAPH EUROPEAN PHARMACOPEIA NOMEN
36 MERCK INDEX MERCK INDEX NOMEN
37 https://en.wikipedia.org/wiki/Alpha-1_adrenergic_receptor WEBSITE NOMEN
38 PHENYLEPHRINE [MART.] SRS_LOCATOR
39 SRS import [1WS297W6MV] SRS NOMEN Fri Apr 28 14:27:59 EDT 2017
40 STN SRS NOMEN

Version

Version Comments

Editor

Change Date

24
admin
Thu Aug 05 00:09:26 EDT 2021

Molecular Formula C9H13NO2
Molecular Weight 167.205
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED